Sektor Perspective Therapeutics, Inc.

Aktien

A40EDR

US46489V3024

CATX

Biotechnologie

Markt geschlossen - 22:00:00 28.09.2026 Perf. 5 T Veränd. 1. Jan.
2.500 USD -0.79% Intraday Chart für Perspective Therapeutics, Inc. -15.82% -9.09%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
-0.79%-15.82%-19.61%-17.76%-9.09%-26.47%-7.41%-60.75%-65.76% 285 Mio.
+0.27%+3.87%+1.39%+8.34%+8.70%+12.47%+37.36%-16.10%+216.51% 49.06 Mrd.
+0.22%+0.40%+3.52%+41.77%+20.21%+50.91%+37.06%+12.16%+240.54% 44.6 Mrd.
-1.58%+4.66%-2.95%+10.80%+153.28%+359.34%+614.38%+603.91% - 43.24 Mrd.
+1.70%+0.36%+0.07%+31.12%+20.80%+12.56%+99.27%+0.88%+1’114.03% 41.73 Mrd.
+0.51%-1.71%-6.50%+7.47%+3.43%+5.18%+46.87%-17.70%+133.42% 29.93 Mrd.
-0.48%-1.32%+2.55%+16.86%+9.67%+23.98%+150.01%+228.38%+1’992.19% 17.19 Mrd.
+0.08%+9.03%+32.85%+51.55%+44.08%+8.41% - - - 15.35 Mrd.
-1.83%-2.13%+6.53%+13.35%+23.85%+27.11%+44.45%-30.13%+91.22% 15.54 Mrd.
+1.97%-3.17%-7.20%-11.77% - - - - - 15.11 Mrd.
+0.60%+5.58%+1.06%+36.54%+47.68%+98.30%+50.83%-29.47%+252.59% 14.06 Mrd.
+1.88%+3.55%+3.26%+3.36%-3.65%+7.19%-28.94%-33.86%+127.19% 13.55 Mrd.
-1.86%+1.88%+21.66%+238.15%+231.88%+155.07%+99.61%+40.68%+1’723.89% 12.21 Mrd.
-0.14%+0.06%+0.22%+2.13%+23.30%+39.85%+6.60%-40.67%+166.80% 11.37 Mrd.
-0.85%-4.43%-1.48%+63.87%+51.71%+28.48%+38.68%-55.67% - 10.86 Mrd.
+0.04%-4.82%-5.21%+3.59%+43.94%+99.11%+683.22%+84.15% - 9.31 Mrd.
+0.41%-1.75%-1.31%+16.87%+63.09%+111.27%+731.52%+681.35%+580.23% 9.22 Mrd.
+1.88%+0.51%+4.41%+14.21%-4.92%-2.60%+1.60%-21.73%+42.24% 9.31 Mrd.
+2.33%-0.69%-12.05%+3.00%-28.74%+21.02%+472.00%+193.33%+1’033.42% 8.31 Mrd.
+1.73%-4.42%-17.14%-12.86%-3.08%+444.72%+1’054.14%-6.70% - 7.98 Mrd.
Durchschnitt +0.30%-0.55%+0.20%+26.03%+36.64%+77.68%+229.51%+85.11%+546.32% 18.91 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +0.24%+1.46%+1.31%+25.90%+41.58%+82.17%+190.79%+102.90%+542.87%
  1. Börse
  2. Aktien
  3. A40EDR Aktie
  4. Sektor Perspective Therapeutics, Inc.
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT